GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Institutional Ownership

Medexus Pharmaceuticals (TSX:MDP) Institutional Ownership : 3.03% (As of Apr. 28, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medexus Pharmaceuticals's institutional ownership is 3.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medexus Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medexus Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.


Medexus Pharmaceuticals Institutional Ownership Historical Data

The historical data trend for Medexus Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Institutional Ownership Chart

Medexus Pharmaceuticals Historical Data

The historical data trend for Medexus Pharmaceuticals can be seen below:

2019-10-31 2019-11-30 2019-12-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 0.68 0.62 0.53 3.63 3.07 3.03 3.03 3.03 3.03 3.03

Medexus Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Medexus Pharmaceuticals (TSX:MDP) Business Description

Traded in Other Exchanges
Address
35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.